Teacher Retirement System of Texas’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,856
Closed -$50K 1943
2023
Q2
$50K Sell
1,856
-348
-16% -$15K ﹤0.01% 1910
2023
Q1
$129K Buy
2,204
+298
+16% +$14.7K ﹤0.01% 1939
2022
Q4
$97K Buy
1,906
+348
+22% +$24.1K ﹤0.01% 1967
2022
Q3
$128K Buy
1,558
+834
+115% +$62.3K ﹤0.01% 2018
2022
Q2
$49K Sell
724
-208
-22% -$19.1K ﹤0.01% 1902
2022
Q1
$103K Buy
932
+58
+7% +$7.23K ﹤0.01% 2066
2021
Q4
$84K Buy
+874
New +$87.1K ﹤0.01% 2151
2018
Q1
Sell
-802
Closed -$115K 2033
2017
Q4
$115K Buy
+802
New +$129K ﹤0.01% 2194
2016
Q3
Sell
-200
Closed -$20K 1722
2016
Q2
$20K Buy
200
+39
+24% +$5.07K ﹤0.01% 2511
2016
Q1
$21K Buy
161
+37
+30% +$4.08K ﹤0.01% 2488
2015
Q4
$25K Sell
124
-37
-23% -$8.01K ﹤0.01% 2418
2015
Q3
$25K Buy
161
+110
+216% +$29.4K ﹤0.01% 2413
2015
Q2
$21K Buy
51
+11
+28% +$4.75K ﹤0.01% 2057
2015
Q1
$18K Buy
40
+11
+38% +$4.74K ﹤0.01% 2007
2014
Q4
$16K Sell
29
-8
-22% -$4.54K ﹤0.01% 2024
2014
Q3
$19K Buy
37
+18
+95% +$10.2K ﹤0.01% 1852
2014
Q2
$13K Buy
+19
New +$8.84K ﹤0.01% 2201

Other funds holding KPTI

Teacher Retirement System of Texas's KPTI Position: Q3 2023 in Review

Teacher Retirement System of Texas sold out of Karyopharm Therapeutics (KPTI) in Q3 2023, closing a stake of 1,856 shares — an estimated $50K sold.

Teacher Retirement System of Texas first reported a position in KPTI in Q2 2014 and held it in 17 quarters. The position peaked at $129K in Q1 2023. 118 funds tracked by Wall St. Rank hold KPTI as of Q3 2023.

  • Teacher Retirement System of Texas reported no remaining Karyopharm Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Teacher Retirement System of Texas sold 1,856 Karyopharm Therapeutics shares in Q3 2023, an estimated $50K.
  • Teacher Retirement System of Texas first reported a position in Karyopharm Therapeutics in Q2 2014 and held it in 17 quarters.
  • Teacher Retirement System of Texas's Karyopharm Therapeutics position peaked at $129K in Q1 2023.
  • 118 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2023.

Based on Teacher Retirement System of Texas's 13F filing for Q3 2023, filed 31 Oct 2023.